Obesity-Induced Inflammation Cooperates with Loss of DNA Methyltransferase 3A to Develop Early-Onset of Leukemia

Authors

  • Taruni Pandhiri Indiana University School of Medicine https://orcid.org/0000-0002-6777-4671
  • Santhosh Kumar Pasupuleti Herman B Wells Center for Pediatric Research, Department of Pediatrics, Indiana University School of Medicine; Department of Microbiology and Immunology, Indiana University School of Medicine
  • Baskar Ramdas Herman B Wells Center for Pediatric Research, Department of Pediatrics, Indiana University School of Medicine; Department of Microbiology and Immunology, Indiana University School of Medicine
  • Rahul Kanumuri Herman B Wells Center for Pediatric Research, Department of Pediatrics, Indiana University School of Medicine; Department of Microbiology and Immunology, Indiana University School of Medicine
  • Reuben Kapur, PhD Herman B Wells Center for Pediatric Research, Department of Pediatrics, Indiana University School of Medicine; Department of Microbiology and Immunology, Indiana University School of Medicine; Department of Medical and Molecular Genetics, Indiana University School of Medicine

DOI:

https://doi.org/10.18060/25762

Abstract

Obesity is an increasing epidemic disease world-wide responsible for enhancing the risk for developing Type 2 diabetes mellitus (T2DM) as well as cancer. However, it is unclear if and how obesity contributes to the transformation of pre-leukemic stem and progenitors (pre-LHSC/Ps) into full-blown leukemia such as acute myeloid leukemia (AML) or severe form of myeloproliferative neoplasm (MPN). We hypothesized that obesity induced chronic inflammation might be responsible for clonal selection of pre-LHSC/Ps bearing pre-leukemic mutations such as DNA methyltransferase 3A (DNMT3A) and for promoting the progression of early-onset MPN towards severe forms of AML/leukemia. To test this hypothesis, we genetically crossed pre-leukemic Dnmt3a+/-;Mx-Cre+ mice with leptin deficient obese (LepOb/Ob) mice to obtain Ob/Ob;Dnmt3a+/-;Mx-Cre+ compound mutant mice. Further, the Dnmt3a gene was deleted by giving the PolyIC and the deletion was confirmed through PCR. After 12 days of post-PolyIC the myeloid cells (neutrophils and monocytes) were expanded in Ob/Ob;Dnmt3a+/-;Mx-Cre+ mice compared to Dnmt3a+/-;Mx-Cre+, Dnmt3a+/-;Mx-Cre-, Ob/Ob and WT mice. We have harvested and analyzed all these mice after 26 days of post-PolyIC. Interestingly, Ob/Ob;Dnmt3a+/-;Mx-Cre+ mice showed increased BM cellularity, both the frequency of lineage negative, Sca-1+ and c-KIT+ (LSK) cells, short-term hematopoietic stem cells (ST-HSCs; LSK/CD48+/CD150-), granulocyte macrophage progenitor (GMPs; LSK/CD16+/CD34+), and reduction in LT-HSCs (LT-HSCs; LSK/CD48-/CD150+) compared to other groups. Flow cytometry analysis of PB, BM and spleen from Ob/Ob;Dnmt3a+/-;Mx-Cre+ mice demonstrated a significant increase in the frequency of mature myeloid cells (Gr-1+/Mac-1+) and a profound reduction in B220+ B cells compared to other groups. Remarkably, these mice also showed splenomegaly, elevated heart size and early signs of AML blasts as reflected by the presence of c-KIT+/CD11b+ double positive cells in the BM, consistent with severe MPN/AML development. Taken together, these results demonstrate that obesity induced inflammation cooperates with pre-leukemic Dnmt3a+/- mutation to induce an early-onset of severe MPN/AML like disease.       

Downloads

Published

2021-12-10

Issue

Section

Abstracts